Abstract
Ferroptosis is closely associated with uterine corpus endometrial carcinoma (UCEC) development. This project aimed to identify new potential biomarkers to predict the prognosis of UCEC. In this work, UCEC transcriptome data along with clinical information was retrieved from the TCGA database including a total of 382 FRGs. We performed univariate Cox regression analysis to evaluate ferroptosis-related genes (FRGs) for prognostic significance. The genes with prognostic significance were then analyzed using LASSO-Cox to construct a prognosis model. The model genes were further characterized through various proteomic analyses and expression detection in clinical samples. A multivariate Cox regression model was constructed containing four FRGs (CDKN1A, CDKN2A, CEBPG, NOS2). Among four FRGs, higher expressions of CDKN2A, CEBPG, and NOS2 were associated with poorer overall survival probability, while higher expression of CDKN1A was associated with better overall survival probability. The area under the receiver operating characteristic curve of the risk model was 0.617, 0.688, and 0.693 for 1 year, 3 years, and 5 years, respectively. Moreover, proteomic analysis showed that the protein expression of CDKN1A, CDKN2A, and CEBPG was higher in tumor tissues than that in normal tissues. Higher protein expression of CDKN1A and CDKN2A predicted poorer survival probability. Besides, CDKN1A protein had an interaction relationship with CDKN2A protein or NOS2 protein. In clinical samples, all four FRGs were upregulated in UCEC tissues, regardless of gene expression or protein expression. Our four FRGs risk model provides new insights for predicting the prognosis of UCEC patients.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13353-023-00779-3/MediaObjects/13353_2023_779_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13353-023-00779-3/MediaObjects/13353_2023_779_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13353-023-00779-3/MediaObjects/13353_2023_779_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13353-023-00779-3/MediaObjects/13353_2023_779_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13353-023-00779-3/MediaObjects/13353_2023_779_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13353-023-00779-3/MediaObjects/13353_2023_779_Fig6_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13353-023-00779-3/MediaObjects/13353_2023_779_Fig7_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13353-023-00779-3/MediaObjects/13353_2023_779_Fig8_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs13353-023-00779-3/MediaObjects/13353_2023_779_Fig9_HTML.png)
Similar content being viewed by others
Data availability
The data could be obtained by contacting the corresponding author.
References
Abu-Zaid A, Alomar O, Abuzaid M, Baradwan S, Salem H, Al-Badawi IA (2021) Preoperative anemia predicts poor prognosis in patients with endometrial cancer: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 258:382–390
Argentiero A, Solimando AG, Krebs M, Leone P, Susca N, Brunetti O et al (2020) Anti-angiogenesis and immunotherapy: novel paradigms to envision tailored approaches in renal cell-carcinoma. J Clin Med 9(5):1594
Bednarz-Misa I, Fleszar MG, Fortuna P, Lewandowski L, Mierzchala-Pasierb M, Diakowska D et al (2021) Altered L-arginine metabolic pathways in gastric cancer: potential therapeutic targets and biomarkers. Biomolecules 11(8):1086
Bielfeld AP, Pour SJ, Poschmann G, Stuhler K, Krussel JS, Baston-Bust DM (2019) A Proteome approach reveals differences between fertile women and patients with repeated implantation failure on endometrial level(-)does hCG render the endometrium of RIF patients? Int J Mol Sci 20(2):425
Brooks RA, Fleming GF, Lastra RR, Lee NK, Moroney JW, Son CH et al (2019) Current recommendations and recent progress in endometrial cancer. CA Cancer J Clin 69(4):258–279
Chen Y, Li H (2022) Prognostic and predictive models for left- and right- colorectal cancer patients: a bioinformatics analysis based on ferroptosis-related genes. Front Oncol 12:833834
Chen X, Kang R, Kroemer G, Tang D (2021) Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol 18(5):280–296
Cheng T, Wu Y, Liu Z, Yu Y, Sun S, Guo M et al (2022) CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer. Front Immunol 13:970950
de Queiroz RM, Moon SH, Prives C (2022) O-GlcNAc transferase regulates p21 protein levels and cell proliferation through the FoxM1-Skp2 axis in a p53-independent manner. J Biol Chem 298(9):102289
Deng Y, Zhang F, Sun ZG, Wang S (2021) Development and validation of a prognostic signature associated with tumor microenvironment based on autophagy-related lncRNA analysis in hepatocellular carcinoma. Front Med (lausanne) 8:762570
Jiang P, Yang F, Zou C, Bao T, Wu M, Yang D et al (2021) The construction and analysis of a ferroptosis-related gene prognostic signature for pancreatic cancer. Aging (albany NY) 13(7):10396–10414
Liu J, Wang Y, Meng H, Yin Y, Zhu H, Ni T (2021) Identification of the prognostic signature associated with tumor immune microenvironment of uterine corpus endometrial carcinoma based on ferroptosis-related genes. Front Cell Dev Biol 9:735013
Lortet-Tieulent J, Ferlay J, Bray F, Jemal A (2018) International patterns and trends in endometrial cancer incidence, 1978–2013. J Natl Cancer Inst 110(4):354–361
Ng SW, Norwitz SG, Taylor HS, Norwitz ER (2020) Endometriosis: the role of iron overload and ferroptosis. Reprod Sci 27(7):1383–1390
Steiner E, Eicher O, Sagemuller J, Schmidt M, Pilch H, Tanner B et al (2003) Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int J Gynecol Cancer 13(2):197–203
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249
Tao YF, Lu J, Du XJ, Sun LC, Zhao X, Peng L et al (2012) Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells. BMC Cancer 12:619
Wang H, Peng S, Cai J, Bao S (2021a) Silencing of PTPN18 induced ferroptosis in endometrial cancer cells through p-p38-mediated GPX4/xCT down-regulation. Cancer Manag Res 13:1757–1765
Wang H, Wu Y, Chen S, Hou M, Yang Y, Xie M (2021b) Construction and validation of a ferroptosis-related prognostic model for endometrial cancer. Front Genet 12:729046
Weijiao Y, Fuchun L, Mengjie C, Xiaoqing Q, Hao L, Yuan L et al (2021) Immune infiltration and a ferroptosis-associated gene signature for predicting the prognosis of patients with endometrial cancer. Aging (albany NY) 13(12):16713–16732
Xiang Y, Lv D, Song T, Niu C, Wang Y (2022) Tumor suppressive role of microRNA-139-5p in bone marrow mesenchymal stem cells-derived extracellular vesicles in bladder cancer through regulation of the KIF3A/p21 axis. Cell Death Dis 13(7):599
Xu W, Anwaier A, Liu W, Wei G, Su J, Tian X et al (2022) Genomic alteration of MTAP/CDKN2A predicts sarcomatoid differentiation and poor prognosis and modulates response to immune checkpoint blockade in renal cell carcinoma. Front Immunol 13:953721
Yuan Y, Cao W, Zhou H, Qian H, Wang H (2021) CLTRN, Regulated by NRF1/RAN/DLD protein complex, enhances radiation sensitivity of hepatocellular carcinoma cells through ferroptosis pathway. Int J Radiat Oncol Biol Phys 110(3):859–871
Zhang M, Zhang T, Song C, Qu J, Gu Y, Liu S et al (2021a) Guizhi Fuling Capsule ameliorates endometrial hyperplasia through promoting p62-Keap1-NRF2-mediated ferroptosis. J Ethnopharmacol 274:114064
Zhang A, Yang J, Ma C, Li F, Luo H (2021b) Development and validation of a robust ferroptosis-related prognostic signature in lung adenocarcinoma. Front Cell Dev Biol 9:616271
Funding
This work was supported by grants from Wenzhou Science and Technology Commission (Y20210354). All data needed to evaluate the conclusions in the paper are presented in the paper.
Author information
Authors and Affiliations
Contributions
Weiwei Jin, Xiaoping Zhuang, and Xiaoying Zhao designed the experiments, performed the experiments, analyzed data, and wrote the paper.
Corresponding author
Ethics declarations
Ethical approval
The ethical approval was granted by Wenzhou Hospital of integrated traditional Chinese and Western medicine, Wenzhou, 325000, China, for the present study under reg. No 2023-L032; however, patients’ consent was not requiring as samples were not collected from human beings. The study is based on bioinformatics approaches and hence did not require any ethical approval.
Conflict of interest
The authors declare no competing interests.
Additional information
Communicated by: Ewa Ziętkiewicz
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jin, W., Zhuang, X., Lin, Y. et al. Integrating ferroptosis-related genes (FRGs) and prognostic models to enhance UCEC outcome prediction and therapeutic insights. J Appl Genetics 64, 723–735 (2023). https://doi.org/10.1007/s13353-023-00779-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13353-023-00779-3